2m 2m 2m 2m 2m 2m 2m
Cytosorbents (CTSO)
NASDAQ
$5.82-$0.19 (-3.14%)
Price as of Oct 23, 2026 4:56 AM EDT- $16.9MMarket Cap
- -64.31%1-Year Change
- Medical DevicesIndustry
Cytosorbents (CTSO)
$5.82-$0.19 (-3.14%)
CTSO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.01 | ||
Change | +$0.66 (+12.34%) | ||
Open | $5.36 | ||
High | $6.96 | ||
Low | $5.36 | ||
Previous Close | $5.35 | ||
Volume | 66,553 | ||
30-Day Average Volume | 57,867 | ||
1-Week Change | 96.41% | ||
1-Month Change | 12.97% | ||
1-Year Change | -64.31% | ||
3-Year Change | -82.32% | ||
5-Year Change | -94.85% | ||
Fundamentals | |||
Shares Outstanding | 3.2M | ||
Total Assets | $38.0M | ||
Market Cap | $16.9M | ||
Enterprise Value | $29.7M | ||
Period: QTR TTM FY | |||
Revenue | $9.6M | ||
Net Income | -$4.4M | ||
Free Cash Flow | -$597,000.00 | ||
EBIT | -$3.5M | ||
EBITDA | -$3.0M | ||
Net Working Capital | -$8.3M | ||
EPS | -$1.40 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 3 | ||
P/B | -22 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/08/2026 | ||
Earnings & Revenue